Search hospitals > Nevada > Las Vegas
Las Vegas Cancer Center-Medical Center
Claim this profileLas Vegas, Nevada 89106
Global Leader in Ovarian Cancer
Global Leader in Lung Cancer
Conducts research for Fallopian Tube Cancer
Conducts research for Cancer
Conducts research for Uterine Cancer
253 reported clinical trials
5 medical researchers
Summary
Las Vegas Cancer Center-Medical Center is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Ovarian Cancer, Lung Cancer, Fallopian Tube Cancer, Cancer, Uterine Cancer and other specialties. Las Vegas Cancer Center-Medical Center is involved with conducting 253 clinical trials across 398 conditions. There are 5 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Nicola M. Spirtos, and Peter Lim.Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
BRCA1 positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation8 years of reported clinical research
Expert in Cancer
Studies Neuroblastoma
55 reported clinical trials
111 drugs studied
Nicola M. SpirtosWomen's Cancer Center of Nevada1 year of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Carcinoma
23 reported clinical trials
50 drugs studied
Peter LimCenter of Hope3 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
13 reported clinical trials
20 drugs studied
Clinical Trials running at Las Vegas Cancer Center-Medical Center
Bladder Cancer
Lung Cancer
Cancer
Ovarian Cancer
Endometrial Cancer
Uterine Cancer
Esophageal cancer
Kidney Cancer
Bladder Carcinoma
Pancreatic Cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Las Vegas Cancer Center-Medical Center?
Las Vegas Cancer Center-Medical Center is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Ovarian Cancer, Lung Cancer, Fallopian Tube Cancer, Cancer, Uterine Cancer and other specialties. Las Vegas Cancer Center-Medical Center is involved with conducting 253 clinical trials across 398 conditions. There are 5 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Nicola M. Spirtos, and Peter Lim.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.